financetom
Business
financetom
/
Business
/
Investors put 'Liberation Day' lessons to work, scarred by tariff tumult
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Investors put 'Liberation Day' lessons to work, scarred by tariff tumult
Jul 8, 2025 11:15 AM

NEW YORK (Reuters) -Three months after President Donald Trump's sweeping global tariffs led markets to plunge and then rebound ferociously, investors are grappling with the fallout from the still-shifting trade backdrop and adjusting strategies to withstand sudden policy shifts.

Among the lessons for investors from Trump's "Liberation Day" tariff announcement on April 2, and the developments since then: Brace for surprises from the Trump administration and be flexible. Pay attention to trade as you would monetary and fiscal policy. Don't over-react to headlines -- but also make your portfolios as resilient as possible to tariff news.

"We're used to just thinking in terms of fiscal and monetary, but now trade policy is almost like this third leg of government policy and how it affects the economy," said Michael Reynolds, vice president of investment strategy at Glenmede.

Investors had been laser-focused on Wednesday, which marked the end of a 90-day pause Trump has placed on many of the most severe "reciprocal" tariffs he had imposed in April on trading partners. The White House on Monday delayed the start of tariffs to August 1, while telling 14 nations that they would face levies ranging from 25% for countries including Japan and South Korea, to 40% for Laos and Myanmar.

"Investors, and the market more broadly, are used to literal interpretations of announcements and what we're realizing with the Trump administration is that is dangerous because there is often flexibility ultimately in the end result," said Mark Hackett, chief market strategist at Nationwide. "We've learned over the last three months there is flexibility." 

Stocks tumbled in the days following the "Liberation Day" announcement, with the S&P 500 falling to the brink of a bear market. Stock and bond volatility spiked, with the daily equity index swings among the most severe since the onset of the coronavirus pandemic in early 2020.

But stocks began climbing back following Trump's pause. A U.S. deal with the U.K. and a truce with China kept the market's momentum going. Volatility measures moderated significantly as well, with the Cboe Volatility index, Wall Street's "fear gauge", falling to its long-term median level.

Helped by a better-than-feared first-quarter earnings season and economic data, the S&P 500 on June 27 hit a record high for the first time in over four months. The benchmark index is now up about 6% for the year.

"Uncertainty at Liberation Day was very open-ended," Reynolds said. "But the outline of a couple of these initial trade deals have kind of narrowed the field of what's probable on tariffs... The fact that we don't have this open-ended risk where tariffs could go anywhere I think is pretty constructive."

Even so, he said, the rebound has been "so swift and large in magnitude that it wouldn't surprise us to see a near-term pullback."

Stocks are not fully factoring in the negative impact to earnings from tariffs that are already in place while investors may be overly optimistic that trade deals will be completed, said Kristina Hooper, chief market strategist at Man Group.

"I'm not convinced that all the pieces are there for the stock market to be as positive as it is," Hooper said.

One lesson from the past few months, Hooper said, is the potential for tariffs to "come out of left field." She pointed to Trump's threat this week that countries aligning themselves with the "Anti-American policies" of the BRICS bloc will be charged an additional 10% tariff. 

"What I've learned is to expect to be surprised," Hooper said.

Some investors have referred to the acronym "TACO", or Trump Always Chickens Out, as a rationale for why markets should not fear the announcement of harsh tariffs because many believe they will likely be moderated.

Heading into this week's initial tariff deadline, King Lip, chief strategist at Baker Avenue Wealth Management, said that market complacency was high and he expects more choppiness as trade uncertainty rises again.

"The biggest risk for investors now is that there is no pause after the trade deadlines and large tariffs are imposed by the administration," Lip said.  

While stocks have rebounded, the U.S. dollar has continued to weaken since Liberation Day, sliding about 6% against a basket of major currencies. Investors have trimmed exposure to U.S. assets while also reassessing the greenback's status as the world's reserve currency because of the uncertain policy backdrop.

Gold, which tends to benefit as a safe-haven asset during times of geopolitical uncertainty, has climbed 6% since April 2 and is up 26% on the year.

Some investors have shifted strategies to manage through tariff uncertainty. 

Janus Henderson Investors has been paring back holdings in some portfolios that could be more vulnerable to tariffs, such as Japanese and European automakers and exporters with long supply chains, said Julian McManus, portfolio manager at the firm. 

Meanwhile, the firm has been favoring service companies that are removed from the crosshairs of the trade war, such as digital services or online music streaming companies.

"We've been extending timelines and making portfolios more resilient," McManus said. "It's just important to keep a cool head and not get caught up in the day-to-day headlines that can be unsettling."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Anixa Biosciences Shares Rise After Notice of Patent Allowance for Breast Cancer Vaccine
Anixa Biosciences Shares Rise After Notice of Patent Allowance for Breast Cancer Vaccine
Apr 9, 2025
02:46 PM EDT, 04/09/2025 (MT Newswires) -- Anixa Biosciences ( ANIX ) shares were up over 10% in recent Wednesday trading after the company said it received a notice of allowance from the US Patent and Trademark Office for its breast cancer vaccine technology. The patent, licensed exclusively from Cleveland Clinic, broadens the scope of immunogenic compositions in the vaccine....
Magnificent Seven to add more than $1 trillion in value after Trump pauses some tariffs
Magnificent Seven to add more than $1 trillion in value after Trump pauses some tariffs
Apr 9, 2025
By Aditya Soni (Reuters) -The Magnificent Seven stocks were poised to gain more than $1 trillion in market value on Wednesday after U.S. President Donald Trump approved a 90-day tariff pause, easing pressure on tech giants that had tumbled in recent sessions. Shares of the companies, which include AI chip giant Nvidia ( NVDA ), Apple, Tesla and Microsoft, were...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
ResMed's Fiscal Q3 Likely to Meet Consensus Estimates; Faces Supply Chain Risks, UBS Says
ResMed's Fiscal Q3 Likely to Meet Consensus Estimates; Faces Supply Chain Risks, UBS Says
Apr 9, 2025
02:45 PM EDT, 04/09/2025 (MT Newswires) -- ResMed's ( RMD ) fiscal Q3 is likely to meet consensus estimates, but the company is facing potential supply chain disruption risks due to US tariffs, UBS said in a Wednesday note. UBS estimates fiscal Q3 revenue of $1.28 billion and a core gross margin of roughly 60%, both in line with Visible...
Copyright 2023-2026 - www.financetom.com All Rights Reserved